data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Applied DNA Sciences

(NASDAQ:APDN)

Intraday

$5.00

0[0.00%]

15 minutes delayed

Perks Buy Compare Brokers

$5.00

0[0.00%]

Last update: 8:30AM Get Real Time Here

Applied DNA Sciences Inc recently split on Thursday, April 25, 2024 with a ratio of 1:20

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for Applied DNA Sciences Stock (NASDAQ:APDN)

Applied DNA Sciences Stock (NASDAQ: APDN)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 25, 2024

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk - 1 day ago

Wednesday, April 24, 2024

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk - 1 day ago
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor - 1 day ago

Monday, April 22, 2024

Applied DNA Announces 1-For-20 Reverse Stock Split, Will Begin Trading On A Split-Adjusted Basis Commencing Upon Market Open On Thursday, April 25, 2024
Benzinga Newsdesk - 3 days ago

Wednesday, March 20, 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Mar 20, 2024, 5:34PM

Monday, March 18, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 18, 2024, 9:05AM

Friday, February 09, 2024

HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Adjusts Price Target To $1.5
Benzinga Newsdesk - Feb 9, 2024, 1:27PM

Thursday, February 08, 2024

Recap: Applied DNA Sciences Q1 Earnings
Benzinga Insights - Feb 8, 2024, 4:40PM
Applied DNA Sciences Q1 2024 GAAP EPS $(0.09) Beats $(0.31) Estimate, Sales $891.16K Beat $776.00K Estimate
Benzinga Newsdesk - Feb 8, 2024, 4:38PM
Earnings Scheduled For February 8, 2024
Benzinga Insights - Feb 8, 2024, 4:43AM

Wednesday, February 07, 2024

Earnings Preview For Applied DNA Sciences
Benzinga Insights - Feb 7, 2024, 3:01PM

Monday, February 05, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Feb 5, 2024, 4:31PM

Wednesday, January 31, 2024

Applied DNA Announces $3.44M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Benzinga Newsdesk - Jan 31, 2024, 8:06AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Jan 31, 2024, 8:05AM
Applied DNA Sciences Said Effective January 30, 2024, Terminated The Equity Distribution Agreement With Maxim Group
Charles Gross - Jan 31, 2024, 6:13AM

Monday, December 18, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Dec 18, 2023, 8:08AM

Thursday, December 14, 2023

Applied DNA Announces Joint Development Agreement To Integrate Linea IVT Platform Into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow
Benzinga Newsdesk - Dec 14, 2023, 8:09AM

Friday, December 08, 2023

Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor - Dec 8, 2023, 7:20AM
HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Lowers Price Target to $2
Benzinga Newsdesk - Dec 8, 2023, 6:58AM

Thursday, December 07, 2023

Applied DNA Sciences: Q4 Earnings Insights
Benzinga Insights - Dec 7, 2023, 4:30PM
Applied DNA Sciences Q4 EPS $(0.26) Down From $(0.06) YoY, Sales $779.74K Down From $3.56M YoY
Benzinga Newsdesk - Dec 7, 2023, 4:10PM
Earnings Scheduled For December 7, 2023
Benzinga Insights - Dec 7, 2023, 5:27AM

Wednesday, December 06, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Dec 6, 2023, 4:31PM

Tuesday, November 28, 2023

Applied DNA Announces Receipt Of Linea DNA Follow-On Order For Cancer Diagnostic Application Valued Above Mid-Six Figures; Deliveries Expected During Fiscal Quarter Ending March 31, 2024 Through Dec. 31, 2024
Benzinga Newsdesk - Nov 28, 2023, 8:35AM

Thursday, November 16, 2023

Applied DNA Extends Application Of Linea IVT Platform To saRNA
Benzinga Newsdesk - Nov 16, 2023, 8:36AM

Thursday, November 09, 2023

Applied DNA Ships First saRNA IVT Template Generated By Linea DNA Platform
Benzinga Newsdesk - Nov 9, 2023, 9:29AM

Thursday, September 28, 2023

Applied DNA Sciences Filed U.S. Patent Application #20230304083: "Methods and Systems of Producing Single Stranded DNA via PCR Using Biotin-Labeled Primers"
Charles Gross - Sep 28, 2023, 11:51AM

Thursday, September 14, 2023

Applied DNA Partners With Cornell University College Of Veterinary Medicine To Accelerate Development Of Veterinary Vaccine Platform Targeting Diseases That Impact High-Value Animals
Benzinga Newsdesk - Sep 14, 2023, 9:17AM

Wednesday, September 06, 2023

Applied DNA Advances Commercialization Of Linea IVT Platform, Appoints Beverly Wolgast As Executive Director Of Quality And cGMP Programs
Happy Mohamed - Sep 6, 2023, 9:20AM

Tuesday, August 29, 2023

Applied DNA Announces Availability And First Customer Shipment Of New Linea IVT Evaluation Kit
Happy Mohamed - Aug 29, 2023, 9:06AM

Thursday, August 24, 2023

HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $4 Price Target
Benzinga Newsdesk - Aug 24, 2023, 6:23AM

Monday, August 14, 2023

HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Lowers Price Target to $4
Benzinga Newsdesk - Aug 14, 2023, 6:43AM

Thursday, August 10, 2023

Applied DNA Sciences Q3 EPS $(0.24), Inline, Sales $2.92M Beat $2.56M Estimate
Benzinga Newsdesk - Aug 10, 2023, 4:11PM
Earnings Scheduled For August 10, 2023
Benzinga Insights - Aug 10, 2023, 6:59AM

Wednesday, August 09, 2023

Earnings Preview: Applied DNA Sciences
Benzinga Insights - Aug 9, 2023, 2:01PM

Friday, July 14, 2023

HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk - Jul 14, 2023, 6:15AM

Thursday, July 13, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Jul 13, 2023, 1:37PM
Applied DNA shares are trading higher after the company announced the acquisition of Spindle Biotech.
Benzinga Newsdesk - Jul 13, 2023, 12:28PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jul 13, 2023, 9:12AM
Market-Moving News for July 13th
Benzinga Newsdesk - Jul 13, 2023, 8:44AM
Applied DNA Acquires RNA Polymerase Developer Spindle Biotech For $0.6M Cash, 0.8M Restricted Shares And Earnout; Launches LineaIVT Platform To Substantially Improve mRNA Manufacturing And Broaden Market Reach
Benzinga Newsdesk - Jul 13, 2023, 7:21AM

Tuesday, May 30, 2023

Applied DNA Sciences Files For Mixed Shelf Of Up To $75M
Benzinga Newsdesk - May 30, 2023, 4:03PM

Friday, May 12, 2023

HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk - May 12, 2023, 7:06AM

Thursday, May 11, 2023

Applied DNA Sciences: Q2 Earnings Insights
Benzinga Insights - May 11, 2023, 4:50PM
Applied DNA Sciences Q2 EPS $0.05 Beats $(0.20) Estimate, Sales $4.40M Beat $4.12M Estimate
Benzinga Newsdesk - May 11, 2023, 4:08PM
Earnings Scheduled For May 11, 2023
Benzinga Insights - May 11, 2023, 9:58AM

Monday, May 08, 2023

HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk - May 8, 2023, 6:26AM

Friday, May 05, 2023

Applied DNA Sciences Says On May 1, 2023 Co.'s Unit Applied DNA Clinical Labs Received Notice Of Termination From City University Of New York
Benzinga Newsdesk - May 5, 2023, 4:07PM

Thursday, March 30, 2023

HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk - Mar 30, 2023, 6:28AM

Wednesday, March 29, 2023

Applied DNA Achieves Milestone For Large-Scale linearDNA Production, Delivers Largest Single Shipment By Volume To Date
Happy Mohamed - Mar 29, 2023, 9:02AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved